SEC Company Response from OptimizeRx Corp (OPRX) (CIK 0001448431) (OPRX) — Jun 14, 2016

OptimizeRx Corp (OPRX) (CIK 0001448431)
Date: June 14, 2016 · CIK: 0001448431 · Accession: 0001213900-16-014211

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-203820, 333-211862

Date

June 14, 2016

Author

Chief

Form

CORRESP

Company

OptimizeRx Corp (OPRX) (CIK 0001448431)

Letter

Division of Corporation Finance Washington, D.C. 20549-7010 Re: OptimizeRx Corp Registration Statement on Form S-1 File No. 333-203820

Dear Ms. Woo:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-211862) to 4:00 PM Eastern Standard Time on June 17, 2016, or as soon thereafter as is practicable.

The Company acknowledges the following:

● Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

● The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

● The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. Please call with any questions.

OptimizeRx Corp

By: /s/ Doug Baker

Doug Baker

Chief Financial Officer

Water Street Suite 200

Rochester, MI, 48307- Phone: 248 651-6568

Show Raw Text

CORRESP
1
filename1.htm

OptimizeRx
Corp

June
14, 2016

THE
UNITED STATES SECURITIES

AND
EXCHANGE COMMISSION

Attn:
Jan Woo

Division
of Corporation Finance

Mail
Stop 7010

100
F. Street NE

Washington,
D.C. 20549-7010

    Re:
    OptimizeRx
    Corp

Registration
Statement on Form S-1

File
No. 333-203820

Dear
Ms. Woo:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration
of the effective date of its Registration Statement on Form S-1 (File No. 333-211862) to 4:00 PM Eastern Standard Time on June
17, 2016, or as soon thereafter as is practicable.

The
Company acknowledges the following:

 ● Should
                                         the Commission or the staff, acting pursuant to delegated authority, declare the filing
                                         effective, it does not foreclose the Commission from taking any action with respect to
                                         the filing;

 ● The
                                         action of the Commission or the staff, acting pursuant to delegated authority, in declaring
                                         the filing effective, does not relieve the Company from its full responsibility for the
                                         adequacy and accuracy of the disclosure in the filing; and

 ● The
                                         Company may not assert staff comments and the declaration of effectiveness as a defense
                                         in any proceeding initiated by the Commission or any person under the federal securities
                                         laws of the United States.

Thank
you for your assistance. Please call with any questions.

OptimizeRx
Corp

    By:
    /s/
    Doug Baker

    Doug
    Baker

    Chief
    Financial Officer

400
Water Street Suite 200

Rochester,
MI, 48307- Phone: 248 651-6568

SecProbe.io